Future work should develop validated risk tools and standardised protocols to guide safe, evidence-based practice
Practical implication: 503A pharmacies can compound semaglutide for individual patients with documented clinical justification (allergy to commercial product excipients, non-standard dose, or documented medical necessity for combination formulation), but cannot operate at the industrial scale that characterized 2022-2024 telehealth compounding
GLP-1 is a hormone produced by the small intestine with multiple roles, including triggering insulin release from the pancreas to reduce blood sugar, blocking glucagon secretion, slowing stomach emptying, and boosting satiety
Every plan is personalized, science-based, and built around your body, not a one-size-fits-all formula
Frequently Asked Questions Is It Possible To Restart GLP-1 Therapy If Weight Regain Occurs